Discovery and characterization of cooperative ligand binding in the adaptive region of interleukin-2

被引:44
作者
Hyde, J [1 ]
Braisted, AC [1 ]
Randal, M [1 ]
Arkin, MR [1 ]
机构
[1] Sunesis Pharmaceut, San Francisco, CA 94080 USA
关键词
D O I
10.1021/bi034138g
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cytokine hormone interieukin-2 (IL-2) contains a highly adaptive region that binds small, druglike molecules. The binding properties of this adaptive region have been explored using a "tethering" method that relies on the formation of a disulfide bond between the protein and small-molecule ligands. Using tethering, surface plasmon resonance (SPR), and X-ray crystallography, we have discovered that the IL-2 adaptive region contains at least two cooperative binding sites where the binding of a first ligand to one site promotes or antagonizes the binding of a second ligand to the second site. Cooperative energies of interaction of -2 kcal/mol are observed. The observation that the adaptive region contains two adjacent sites may lead to the development of tight-binding antagonists of a protein-protein interaction. Cooperative ligand binding in the adaptive region of IL-2 underscores the importance of protein dynamics in molecular recognition. The tethering approach provides a novel and general strategy for discovering such cooperative binding interactions in specific, flexible regions of protein structure.
引用
收藏
页码:6475 / 6483
页数:9
相关论文
共 41 条
[1]   Binding of small molecules to an adaptive protein-protein interface [J].
Arkin, MR ;
Randal, M ;
DeLano, WL ;
Hyde, J ;
Luong, TN ;
Oslob, JD ;
Raphael, DR ;
Taylor, L ;
Wang, J ;
McDowell, RS ;
Wells, JA ;
Braisted, AC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) :1603-1608
[2]   A review of interleukin-2 receptor antagonists in solid organ transplantation [J].
Berard, JL ;
Velez, RL ;
Freeman, RB ;
Tsunoda, SM .
PHARMACOTHERAPY, 1999, 19 (10) :1127-1137
[3]   Prophylactic and therapeutic effects of a humanized monoclonal antibody against the IL-2 receptor (DACLIZUMAB) on collagen-induced arthritis (CIA) in rhesus monkeys [J].
Brok, HPM ;
Tekoppele, JM ;
Hakimi, J ;
Kerwin, JA ;
Nijenhuis, EM ;
De Groot, CW ;
Bontrop, RE ;
't Hart, BA .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 124 (01) :134-141
[4]   Designing non-peptide peptidomimetics in the 21st century: Inhibitors targeting conformational ensembles [J].
Bursavich, MG ;
Rich, DH .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (03) :541-558
[5]   Dadizumab - A review of its use in the management of organ transplantation [J].
Carswell, CI ;
Plosker, GL ;
Wagstaff, AJ .
BIODRUGS, 2001, 15 (11) :745-773
[6]   Protein-protein interfaces: mimics and inhibitors [J].
Cochran, AG .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2001, 5 (06) :654-659
[7]   Antagonists of protein-protein interactions [J].
Cochran, AG .
CHEMISTRY & BIOLOGY, 2000, 7 (04) :R85-R94
[8]  
*COLL COMP PROJ 4, 1994, ACTA CRYSTALLOGR D, V55, P1718
[9]   Convergent solutions to binding at a protein-protein interface [J].
DeLano, WL ;
Ultsch, MH ;
de Vos, AM ;
Wells, JA .
SCIENCE, 2000, 287 (5456) :1279-1283
[10]   In situ assembly of enzyme inhibitors using extended tethering [J].
Erlanson, DA ;
Lam, JW ;
Wiesmann, C ;
Luong, TN ;
Simmons, RL ;
DeLano, WL ;
Choong, IC ;
Burdett, MT ;
Flanagan, WM ;
Lee, D ;
Gordon, EM ;
O'Brien, T .
NATURE BIOTECHNOLOGY, 2003, 21 (03) :308-314